14 reports

The improving health infrastructure in Africa due to the growing prevalence of cancer, HIV/ AIDS, and genetic diseases is increasing the adoption of prenatal DNA sequencing in the continent.

  • Genetic Disorder
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • Natera, Inc.

Gilead' s product portfolio and pipeline of investigational drugs encompasses treatments for HIV/ AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions.

  • Genetic Disorder
  • AbbVie Inc.
  • Allergan plc
  • Pharmaxis Ltd
  • Vertex Pharmaceuticals Incorporated

Gilead' s product portfolio and pipeline of investigational drugs encompasses treatments for HIV/ AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions.

  • Genetic Disorder
  • AbbVie Inc.
  • Allergan plc
  • Pharmaxis Ltd
  • Vertex Pharmaceuticals Incorporated

Engages in the development of drugs for HIV/ AIDS, liver diseases, hematology, oncology, cardiovascular, inflammation, respiratory, and other therapies.

  • Genetic Disorder
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG
  • Royalty Pharma Acquires Royalties on Cystic Fibrosis Treatments from Cystic Fibrosis Foundation Therapeutics for USD3.3 Billion

The company offers its products in the therapeutic areas of rheumatoid arthritis (RA), chronic kidney disease, Crohn' s disease, diabetes, HIV/ AIDS and others.

  • Genetic Disorder
  • United States
  • Company Financials
  • M&A
  • RP Management LLC

In August 2004, National Institute of Allergy and Infectious Diseases (NIAID) registered a Phase IB/ IIA dose-finding safety and activity study to test the safety and anti-HIV activity of eight different doses of the HIV entry inhibitor AMD-## in HIV infected patien

  • Blood Supply
  • Genetic Disorder
  • Infectious Disease
  • Therapy
  • ADMA Biologics, Inc.

Also, the approved drugs-Strimvelis and Kymriah-transfer genes using retroviruses. ##. ## RETROVIRAL VECTORS ##. ##. ## L E N T I V I R A L V E C T O R S Lentiviral vectors include modified human immunodeficiency viruses ## (HIV-##) and ## (HIV-##).

  • Genetic Disorder
  • Viral Vector
  • North America
  • United States
  • Market Size

In August 2004, National Institute of Allergy and Infectious Diseases (NIAID) registered a Phase IB/ IIA dose-finding safety and activity study to test the safety and anti-HIV activity of eight different doses of the HIV entry inhibitor AMD-## in HIV infected patien

  • Genetic Disorder
  • Infectious Disease
  • Therapy
  • United States
  • Product Initiative
  • ROYALTY PHARMA ACQUIRES ROYALTIES ON CYSTIC FIBROSIS TREATMENTS FROM CYSTIC FIBROSIS FOUNDATION THERAPEUTICS FOR USD3.3 BILLION

The company offers its products in the therapeutic areas of rheumatoid arthritis (RA), chronic kidney disease, Crohn' s disease, diabetes, HIV/ AIDS and others.

  • Cystic Fibrosis
  • Genetic Disorder
  • Therapy
  • United States
  • Proteostasis Therapeutics, Inc.

The prominent features of this report are - ##.

  • Clinical Trial
  • Genetic Disorder
  • Therapy
  • World
  • Product Initiative

The MGH Research Institute conducts the largest hospital-based research program in the nation, with an annual research budget of more than $## million and major research centers in HIV/ AIDS, cardiovascular research, cancer, computational and integrative biology, cutaneous bio

  • Genetic Disorder
  • Therapy
  • World
  • Product Initiative
  • F. Hoffmann-La Roche Ltd.
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Genetic Disorder
  • Infectious Disease
  • Therapy
  • CSL Limited
  • Clinical Trial profile. 188 Trial Title
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Genetic Disorder
  • Neurological Disorder
  • Therapy
  • World
  • Apr 10, 2017: Research Uncovers Potential New Treatment to Treat and Stop Progression of Cystic Fibrosis

T& alpha##, whose commercial name is Zadaxin, has been approved for clinical use for over ## years in ## countries in the treatment of patients with viral infections, immunodeficiency diseases, malignancies, and HIV/ AIDS.

  • Genetic Disorder
  • Pharmaceutical
  • United States
  • Deals & Alliance
  • La Jolla Pharmaceutical Company